Your Article Summary
FDA Approves Pennsaid(R) Topical Solution
Covidien, 11/10/09
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, announced that the U.S. Food and Drug Administration has approved the New Drug Application for Pennsaid Topical Solution 1.5% w/w.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Article Search
Sponsor


See Latest Articles


